It is also worth further investigating whether FTO O-GlcNAcylation is associated with other aberrant FTO-mediated m6A-related diseases, such as diabetes mellitus, hepatic fibrosis, melanoma, and other various malignancies by using more mouse models and clinical samples. Here, FTO is linked to diabetes mellitus.